Priorities of human papillomavirus-associated oropharyngeal cancer patients at diagnosis and after treatment
• Treatment-related priorities of HPV-OPC are similar through treatment. • The importance of having a moist mouth increases after treatment. • Concern regarding treatment-relates issues generally declines after treatment.
Gespeichert in:
| Autor*in: |
Windon, Melina J. [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2019 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
5 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole - 2012transfer abstract, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:95 ; year:2019 ; pages:11-15 ; extent:5 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.oraloncology.2019.05.016 |
|---|
| Katalog-ID: |
ELV047397683 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV047397683 | ||
| 003 | DE-627 | ||
| 005 | 20230624134426.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 191021s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.oraloncology.2019.05.016 |2 doi | |
| 028 | 5 | 2 | |a GBV00000000000695.pica |
| 035 | |a (DE-627)ELV047397683 | ||
| 035 | |a (ELSEVIER)S1368-8375(19)30163-0 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 082 | 0 | 4 | |a 650 |q VZ |
| 084 | |a 85.03 |2 bkl | ||
| 084 | |a 31.80 |2 bkl | ||
| 084 | |a 54.80 |2 bkl | ||
| 084 | |a 50.03 |2 bkl | ||
| 100 | 1 | |a Windon, Melina J. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Priorities of human papillomavirus-associated oropharyngeal cancer patients at diagnosis and after treatment |
| 264 | 1 | |c 2019 | |
| 300 | |a 5 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a • Treatment-related priorities of HPV-OPC are similar through treatment. • The importance of having a moist mouth increases after treatment. • Concern regarding treatment-relates issues generally declines after treatment. | ||
| 650 | 7 | |a Decision-making |2 Elsevier | |
| 650 | 7 | |a Oropharyngeal neoplasms |2 Elsevier | |
| 650 | 7 | |a Head and neck neoplasms |2 Elsevier | |
| 650 | 7 | |a Patient preference |2 Elsevier | |
| 650 | 7 | |a HPV |2 Elsevier | |
| 700 | 1 | |a Fakhry, Carole |4 oth | |
| 700 | 1 | |a Faraji, Farhoud |4 oth | |
| 700 | 1 | |a Troy, Tanya |4 oth | |
| 700 | 1 | |a Gourin, Christine G. |4 oth | |
| 700 | 1 | |a Kiess, Ana P. |4 oth | |
| 700 | 1 | |a Koch, Wayne |4 oth | |
| 700 | 1 | |a Eisele, David W. |4 oth | |
| 700 | 1 | |a D'Souza, Gypsyamber |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier Science |t Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole |d 2012transfer abstract |g Amsterdam [u.a.] |w (DE-627)ELV011194073 |
| 773 | 1 | 8 | |g volume:95 |g year:2019 |g pages:11-15 |g extent:5 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.oraloncology.2019.05.016 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OPC-MAT | ||
| 936 | b | k | |a 85.03 |j Methoden und Techniken der Betriebswirtschaft |q VZ |
| 936 | b | k | |a 31.80 |j Angewandte Mathematik |q VZ |
| 936 | b | k | |a 54.80 |j Angewandte Informatik |q VZ |
| 936 | b | k | |a 50.03 |j Methoden und Techniken der Ingenieurwissenschaften |q VZ |
| 951 | |a AR | ||
| 952 | |d 95 |j 2019 |h 11-15 |g 5 | ||
| author_variant |
m j w mj mjw |
|---|---|
| matchkey_str |
windonmelinajfakhrycarolefarajifarhoudtr:2019----:roiisfuapploaiuascaeoohrnelacrainsti |
| hierarchy_sort_str |
2019 |
| bklnumber |
85.03 31.80 54.80 50.03 |
| publishDate |
2019 |
| allfields |
10.1016/j.oraloncology.2019.05.016 doi GBV00000000000695.pica (DE-627)ELV047397683 (ELSEVIER)S1368-8375(19)30163-0 DE-627 ger DE-627 rakwb eng 610 VZ 650 VZ 85.03 bkl 31.80 bkl 54.80 bkl 50.03 bkl Windon, Melina J. verfasserin aut Priorities of human papillomavirus-associated oropharyngeal cancer patients at diagnosis and after treatment 2019 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Treatment-related priorities of HPV-OPC are similar through treatment. • The importance of having a moist mouth increases after treatment. • Concern regarding treatment-relates issues generally declines after treatment. Decision-making Elsevier Oropharyngeal neoplasms Elsevier Head and neck neoplasms Elsevier Patient preference Elsevier HPV Elsevier Fakhry, Carole oth Faraji, Farhoud oth Troy, Tanya oth Gourin, Christine G. oth Kiess, Ana P. oth Koch, Wayne oth Eisele, David W. oth D'Souza, Gypsyamber oth Enthalten in Elsevier Science Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole 2012transfer abstract Amsterdam [u.a.] (DE-627)ELV011194073 volume:95 year:2019 pages:11-15 extent:5 https://doi.org/10.1016/j.oraloncology.2019.05.016 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-MAT 85.03 Methoden und Techniken der Betriebswirtschaft VZ 31.80 Angewandte Mathematik VZ 54.80 Angewandte Informatik VZ 50.03 Methoden und Techniken der Ingenieurwissenschaften VZ AR 95 2019 11-15 5 |
| spelling |
10.1016/j.oraloncology.2019.05.016 doi GBV00000000000695.pica (DE-627)ELV047397683 (ELSEVIER)S1368-8375(19)30163-0 DE-627 ger DE-627 rakwb eng 610 VZ 650 VZ 85.03 bkl 31.80 bkl 54.80 bkl 50.03 bkl Windon, Melina J. verfasserin aut Priorities of human papillomavirus-associated oropharyngeal cancer patients at diagnosis and after treatment 2019 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Treatment-related priorities of HPV-OPC are similar through treatment. • The importance of having a moist mouth increases after treatment. • Concern regarding treatment-relates issues generally declines after treatment. Decision-making Elsevier Oropharyngeal neoplasms Elsevier Head and neck neoplasms Elsevier Patient preference Elsevier HPV Elsevier Fakhry, Carole oth Faraji, Farhoud oth Troy, Tanya oth Gourin, Christine G. oth Kiess, Ana P. oth Koch, Wayne oth Eisele, David W. oth D'Souza, Gypsyamber oth Enthalten in Elsevier Science Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole 2012transfer abstract Amsterdam [u.a.] (DE-627)ELV011194073 volume:95 year:2019 pages:11-15 extent:5 https://doi.org/10.1016/j.oraloncology.2019.05.016 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-MAT 85.03 Methoden und Techniken der Betriebswirtschaft VZ 31.80 Angewandte Mathematik VZ 54.80 Angewandte Informatik VZ 50.03 Methoden und Techniken der Ingenieurwissenschaften VZ AR 95 2019 11-15 5 |
| allfields_unstemmed |
10.1016/j.oraloncology.2019.05.016 doi GBV00000000000695.pica (DE-627)ELV047397683 (ELSEVIER)S1368-8375(19)30163-0 DE-627 ger DE-627 rakwb eng 610 VZ 650 VZ 85.03 bkl 31.80 bkl 54.80 bkl 50.03 bkl Windon, Melina J. verfasserin aut Priorities of human papillomavirus-associated oropharyngeal cancer patients at diagnosis and after treatment 2019 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Treatment-related priorities of HPV-OPC are similar through treatment. • The importance of having a moist mouth increases after treatment. • Concern regarding treatment-relates issues generally declines after treatment. Decision-making Elsevier Oropharyngeal neoplasms Elsevier Head and neck neoplasms Elsevier Patient preference Elsevier HPV Elsevier Fakhry, Carole oth Faraji, Farhoud oth Troy, Tanya oth Gourin, Christine G. oth Kiess, Ana P. oth Koch, Wayne oth Eisele, David W. oth D'Souza, Gypsyamber oth Enthalten in Elsevier Science Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole 2012transfer abstract Amsterdam [u.a.] (DE-627)ELV011194073 volume:95 year:2019 pages:11-15 extent:5 https://doi.org/10.1016/j.oraloncology.2019.05.016 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-MAT 85.03 Methoden und Techniken der Betriebswirtschaft VZ 31.80 Angewandte Mathematik VZ 54.80 Angewandte Informatik VZ 50.03 Methoden und Techniken der Ingenieurwissenschaften VZ AR 95 2019 11-15 5 |
| allfieldsGer |
10.1016/j.oraloncology.2019.05.016 doi GBV00000000000695.pica (DE-627)ELV047397683 (ELSEVIER)S1368-8375(19)30163-0 DE-627 ger DE-627 rakwb eng 610 VZ 650 VZ 85.03 bkl 31.80 bkl 54.80 bkl 50.03 bkl Windon, Melina J. verfasserin aut Priorities of human papillomavirus-associated oropharyngeal cancer patients at diagnosis and after treatment 2019 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Treatment-related priorities of HPV-OPC are similar through treatment. • The importance of having a moist mouth increases after treatment. • Concern regarding treatment-relates issues generally declines after treatment. Decision-making Elsevier Oropharyngeal neoplasms Elsevier Head and neck neoplasms Elsevier Patient preference Elsevier HPV Elsevier Fakhry, Carole oth Faraji, Farhoud oth Troy, Tanya oth Gourin, Christine G. oth Kiess, Ana P. oth Koch, Wayne oth Eisele, David W. oth D'Souza, Gypsyamber oth Enthalten in Elsevier Science Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole 2012transfer abstract Amsterdam [u.a.] (DE-627)ELV011194073 volume:95 year:2019 pages:11-15 extent:5 https://doi.org/10.1016/j.oraloncology.2019.05.016 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-MAT 85.03 Methoden und Techniken der Betriebswirtschaft VZ 31.80 Angewandte Mathematik VZ 54.80 Angewandte Informatik VZ 50.03 Methoden und Techniken der Ingenieurwissenschaften VZ AR 95 2019 11-15 5 |
| allfieldsSound |
10.1016/j.oraloncology.2019.05.016 doi GBV00000000000695.pica (DE-627)ELV047397683 (ELSEVIER)S1368-8375(19)30163-0 DE-627 ger DE-627 rakwb eng 610 VZ 650 VZ 85.03 bkl 31.80 bkl 54.80 bkl 50.03 bkl Windon, Melina J. verfasserin aut Priorities of human papillomavirus-associated oropharyngeal cancer patients at diagnosis and after treatment 2019 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Treatment-related priorities of HPV-OPC are similar through treatment. • The importance of having a moist mouth increases after treatment. • Concern regarding treatment-relates issues generally declines after treatment. Decision-making Elsevier Oropharyngeal neoplasms Elsevier Head and neck neoplasms Elsevier Patient preference Elsevier HPV Elsevier Fakhry, Carole oth Faraji, Farhoud oth Troy, Tanya oth Gourin, Christine G. oth Kiess, Ana P. oth Koch, Wayne oth Eisele, David W. oth D'Souza, Gypsyamber oth Enthalten in Elsevier Science Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole 2012transfer abstract Amsterdam [u.a.] (DE-627)ELV011194073 volume:95 year:2019 pages:11-15 extent:5 https://doi.org/10.1016/j.oraloncology.2019.05.016 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-MAT 85.03 Methoden und Techniken der Betriebswirtschaft VZ 31.80 Angewandte Mathematik VZ 54.80 Angewandte Informatik VZ 50.03 Methoden und Techniken der Ingenieurwissenschaften VZ AR 95 2019 11-15 5 |
| language |
English |
| source |
Enthalten in Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole Amsterdam [u.a.] volume:95 year:2019 pages:11-15 extent:5 |
| sourceStr |
Enthalten in Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole Amsterdam [u.a.] volume:95 year:2019 pages:11-15 extent:5 |
| format_phy_str_mv |
Article |
| bklname |
Methoden und Techniken der Betriebswirtschaft Angewandte Mathematik Angewandte Informatik Methoden und Techniken der Ingenieurwissenschaften |
| institution |
findex.gbv.de |
| topic_facet |
Decision-making Oropharyngeal neoplasms Head and neck neoplasms Patient preference HPV |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole |
| authorswithroles_txt_mv |
Windon, Melina J. @@aut@@ Fakhry, Carole @@oth@@ Faraji, Farhoud @@oth@@ Troy, Tanya @@oth@@ Gourin, Christine G. @@oth@@ Kiess, Ana P. @@oth@@ Koch, Wayne @@oth@@ Eisele, David W. @@oth@@ D'Souza, Gypsyamber @@oth@@ |
| publishDateDaySort_date |
2019-01-01T00:00:00Z |
| hierarchy_top_id |
ELV011194073 |
| dewey-sort |
3610 |
| id |
ELV047397683 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV047397683</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624134426.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">191021s2019 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.oraloncology.2019.05.016</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000695.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV047397683</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1368-8375(19)30163-0</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">650</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">85.03</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">31.80</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">54.80</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">50.03</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Windon, Melina J.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Priorities of human papillomavirus-associated oropharyngeal cancer patients at diagnosis and after treatment</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2019</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">5</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• Treatment-related priorities of HPV-OPC are similar through treatment. • The importance of having a moist mouth increases after treatment. • Concern regarding treatment-relates issues generally declines after treatment.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Decision-making</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Oropharyngeal neoplasms</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Head and neck neoplasms</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Patient preference</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HPV</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fakhry, Carole</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Faraji, Farhoud</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Troy, Tanya</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gourin, Christine G.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kiess, Ana P.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Koch, Wayne</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Eisele, David W.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">D'Souza, Gypsyamber</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="t">Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole</subfield><subfield code="d">2012transfer abstract</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV011194073</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:95</subfield><subfield code="g">year:2019</subfield><subfield code="g">pages:11-15</subfield><subfield code="g">extent:5</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.oraloncology.2019.05.016</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-MAT</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">85.03</subfield><subfield code="j">Methoden und Techniken der Betriebswirtschaft</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">31.80</subfield><subfield code="j">Angewandte Mathematik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">54.80</subfield><subfield code="j">Angewandte Informatik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">50.03</subfield><subfield code="j">Methoden und Techniken der Ingenieurwissenschaften</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">95</subfield><subfield code="j">2019</subfield><subfield code="h">11-15</subfield><subfield code="g">5</subfield></datafield></record></collection>
|
| author |
Windon, Melina J. |
| spellingShingle |
Windon, Melina J. ddc 610 ddc 650 bkl 85.03 bkl 31.80 bkl 54.80 bkl 50.03 Elsevier Decision-making Elsevier Oropharyngeal neoplasms Elsevier Head and neck neoplasms Elsevier Patient preference Elsevier HPV Priorities of human papillomavirus-associated oropharyngeal cancer patients at diagnosis and after treatment |
| authorStr |
Windon, Melina J. |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV011194073 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health 650 - Management & auxiliary services |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 VZ 650 VZ 85.03 bkl 31.80 bkl 54.80 bkl 50.03 bkl Priorities of human papillomavirus-associated oropharyngeal cancer patients at diagnosis and after treatment Decision-making Elsevier Oropharyngeal neoplasms Elsevier Head and neck neoplasms Elsevier Patient preference Elsevier HPV Elsevier |
| topic |
ddc 610 ddc 650 bkl 85.03 bkl 31.80 bkl 54.80 bkl 50.03 Elsevier Decision-making Elsevier Oropharyngeal neoplasms Elsevier Head and neck neoplasms Elsevier Patient preference Elsevier HPV |
| topic_unstemmed |
ddc 610 ddc 650 bkl 85.03 bkl 31.80 bkl 54.80 bkl 50.03 Elsevier Decision-making Elsevier Oropharyngeal neoplasms Elsevier Head and neck neoplasms Elsevier Patient preference Elsevier HPV |
| topic_browse |
ddc 610 ddc 650 bkl 85.03 bkl 31.80 bkl 54.80 bkl 50.03 Elsevier Decision-making Elsevier Oropharyngeal neoplasms Elsevier Head and neck neoplasms Elsevier Patient preference Elsevier HPV |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
c f cf f f ff t t tt c g g cg cgg a p k ap apk w k wk d w e dw dwe g d gd |
| hierarchy_parent_title |
Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole |
| hierarchy_parent_id |
ELV011194073 |
| dewey-tens |
610 - Medicine & health 650 - Management & public relations |
| hierarchy_top_title |
Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV011194073 |
| title |
Priorities of human papillomavirus-associated oropharyngeal cancer patients at diagnosis and after treatment |
| ctrlnum |
(DE-627)ELV047397683 (ELSEVIER)S1368-8375(19)30163-0 |
| title_full |
Priorities of human papillomavirus-associated oropharyngeal cancer patients at diagnosis and after treatment |
| author_sort |
Windon, Melina J. |
| journal |
Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole |
| journalStr |
Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2019 |
| contenttype_str_mv |
zzz |
| container_start_page |
11 |
| author_browse |
Windon, Melina J. |
| container_volume |
95 |
| physical |
5 |
| class |
610 VZ 650 VZ 85.03 bkl 31.80 bkl 54.80 bkl 50.03 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Windon, Melina J. |
| doi_str_mv |
10.1016/j.oraloncology.2019.05.016 |
| dewey-full |
610 650 |
| title_sort |
priorities of human papillomavirus-associated oropharyngeal cancer patients at diagnosis and after treatment |
| title_auth |
Priorities of human papillomavirus-associated oropharyngeal cancer patients at diagnosis and after treatment |
| abstract |
• Treatment-related priorities of HPV-OPC are similar through treatment. • The importance of having a moist mouth increases after treatment. • Concern regarding treatment-relates issues generally declines after treatment. |
| abstractGer |
• Treatment-related priorities of HPV-OPC are similar through treatment. • The importance of having a moist mouth increases after treatment. • Concern regarding treatment-relates issues generally declines after treatment. |
| abstract_unstemmed |
• Treatment-related priorities of HPV-OPC are similar through treatment. • The importance of having a moist mouth increases after treatment. • Concern regarding treatment-relates issues generally declines after treatment. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-MAT |
| title_short |
Priorities of human papillomavirus-associated oropharyngeal cancer patients at diagnosis and after treatment |
| url |
https://doi.org/10.1016/j.oraloncology.2019.05.016 |
| remote_bool |
true |
| author2 |
Fakhry, Carole Faraji, Farhoud Troy, Tanya Gourin, Christine G. Kiess, Ana P. Koch, Wayne Eisele, David W. D'Souza, Gypsyamber |
| author2Str |
Fakhry, Carole Faraji, Farhoud Troy, Tanya Gourin, Christine G. Kiess, Ana P. Koch, Wayne Eisele, David W. D'Souza, Gypsyamber |
| ppnlink |
ELV011194073 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth oth |
| doi_str |
10.1016/j.oraloncology.2019.05.016 |
| up_date |
2024-07-06T22:47:01.255Z |
| _version_ |
1803871606545580032 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV047397683</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624134426.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">191021s2019 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.oraloncology.2019.05.016</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000695.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV047397683</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1368-8375(19)30163-0</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">650</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">85.03</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">31.80</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">54.80</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">50.03</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Windon, Melina J.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Priorities of human papillomavirus-associated oropharyngeal cancer patients at diagnosis and after treatment</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2019</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">5</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• Treatment-related priorities of HPV-OPC are similar through treatment. • The importance of having a moist mouth increases after treatment. • Concern regarding treatment-relates issues generally declines after treatment.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Decision-making</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Oropharyngeal neoplasms</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Head and neck neoplasms</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Patient preference</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HPV</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fakhry, Carole</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Faraji, Farhoud</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Troy, Tanya</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gourin, Christine G.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kiess, Ana P.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Koch, Wayne</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Eisele, David W.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">D'Souza, Gypsyamber</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="t">Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole</subfield><subfield code="d">2012transfer abstract</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV011194073</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:95</subfield><subfield code="g">year:2019</subfield><subfield code="g">pages:11-15</subfield><subfield code="g">extent:5</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.oraloncology.2019.05.016</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-MAT</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">85.03</subfield><subfield code="j">Methoden und Techniken der Betriebswirtschaft</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">31.80</subfield><subfield code="j">Angewandte Mathematik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">54.80</subfield><subfield code="j">Angewandte Informatik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">50.03</subfield><subfield code="j">Methoden und Techniken der Ingenieurwissenschaften</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">95</subfield><subfield code="j">2019</subfield><subfield code="h">11-15</subfield><subfield code="g">5</subfield></datafield></record></collection>
|
| score |
7.4004297 |